CHOCO-CABANA Trial
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Atherosclerosis
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: 120 patients (60 per group) Special balloon (chocolate balloon with a special nitiol cage around the balloon - not drug coated) versus standard uncoated balloonMasking: Single (Participant)Masking Description: Randomization per envelopePrimary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04539145
- Collaborators
- Hanusch-Krankenhaus Kardiovaskuläres Zentrum
- Medtronic
- Herz-Zentrums Bad Krozingen
- University Hospital Tuebingen
- Klinikum Karlsbad-Langensteinbach
- Elblandklinikum Radebeul Interdisziplinäres Gefäßzentrum Radebeul / Riesa
- LKH-Universitätsklinikum Graz Univ. Klinik für Innere Medizin Klin. Abteilung für Angiologie
- Auckland City Hospital
- SCO:SSiS
- coreLab Black Forest GmbH
- Charite University, Berlin, Germany
- Investigators
- Not Provided